Next Article in Journal
Swedish High School Students’ Drug and Alcohol Use Habits throughout 2020
Previous Article in Journal
Lessons Learned from the COVID-19 Pandemic in Nursing Homes: A Systematic Review
Previous Article in Special Issue
High-Intensity Interval Training (HIIT) in Hypoxia Improves Maximal Aerobic Capacity More Than HIIT in Normoxia: A Systematic Review, Meta-Analysis, and Meta-Regression
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJERPH
Volume 19
Issue 24
10.3390/ijerph192416926
ijerph-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Utility of High Intensity Interval Training to Improve Cognitive Aging in Heart Disease Patients

by
Jenna L. Taylor
1,2,*,
Jill N. Barnes
3 and
Bruce D. Johnson
1,2
1
Human Integrative and Environmental Physiology Laboratory, Mayo Clinic, Rochester, MN 55902, USA
2
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55902, USA
3
Bruno Balke Biodynamics Laboratory, Department of Kinesiology, University of Wisconsin-Madison, Madison, WI 53706, USA
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2022, 19(24), 16926; https://doi.org/10.3390/ijerph192416926
Submission received: 11 November 2022 / Revised: 6 December 2022 / Accepted: 13 December 2022 / Published: 16 December 2022
(This article belongs to the Special Issue The Health Outcomes of High-Intensity Interval Exercise and Training)
Browse Figure
Review Reports Versions Notes

Abstract

:
Adults with cardiovascular disease and heart failure are at higher risk of cognitive decline. Cerebral hypoperfusion appears to be a significant contributor, which can result from vascular dysfunction and impairment of cerebral blood flow regulation. In contrast, higher cardiorespiratory fitness shows protection against brain atrophy, reductions in cerebral blood flow, and cognitive decline. Given that high intensity interval training (HIIT) has been shown to be a potent stimulus for improving cardiorespiratory fitness and peripheral vascular function, its utility for improving cognitive aging is an important area of research. This article will review the physiology related to cerebral blood flow regulation and cognitive decline in adults with cardiovascular disease and heart failure, and how HIIT may provide a more optimal stimulus for improving cognitive aging in this population.

1. Introduction

Dementia is a debilitating disease that impairs a person’s memory and cognitive functions for maintaining independence and normal daily activities. Mild cognitive impairment is a term used to characterize individuals that fall between the cognitive changes of normal aging and dementia but still have the ability to perform usual daily activities and live in an autonomous manner [1]. Globally, it is estimated that around 47 million people are living with dementia-related disease, which is expected to triple by the year 2050 [2]. Vascular dementia and the neurodegenerative condition Alzheimer’s disease are the two most common causes of dementia. Although Alzheimer’s disease has distinct pathology from vascular dementia (e.g., β-amyloid plaques and neurofibrillary tangles of tau protein), they frequently coexist and can simultaneously contribute to cognitive impairment [3]. Moreover, 30% of Alzheimer’s disease cases have been attributed to modifiable vascular risk factors such as hypertension, obesity, diabetes, physical inactivity [4].
Cardiovascular disease (CVD) affects >400 million people worldwide [5] and 120 million people in the United States alone [6]. While the incidence of dementia increases with age, adults with CVD have a higher risk of cognitive impairment [7,8]. Furthermore, a cardiovascular event or the onset of heart failure (HF) accelerates the cognitive decline [9,10]. Reduced blood flow to the brain (i.e., cerebral hypoperfusion) appears to be a significant contributor to cognitive decline [11]. Although reductions in cerebral blood flow (CBF) occur with normal aging [12,13] the age-related decline may be exacerbated by the presence of CVD. Indeed, patients with coronary artery disease have shown reduced CBF and greater rates of brain atrophy compared with age-matched controls [14,15]. Due to medical advancements, patients with CVD are now living for many decades [16]. Therefore, the impact of CVD on the aging brain and cognitive decline is of increasing importance.
This article will provide an overview of the pathophysiology that contributes to cerebral hypoperfusion and cognitive decline in adults with CVD including HF, and potential mechanisms for how exercise promotes better brain health. Furthermore, this article will review the current evidence on whether exercise training may improve brain health in patients with CVD, and how high intensity interval training (HIIT) may provide a more optimal stimulus.

2. Cerebral Blood Flow Regulation

Adequate CBF as well as the structural and functional integrity of cerebral blood vessels are essential to normal brain functioning [17]. Reduced CBF and impaired cerebrovascular function represent early physiological markers of neurocognitive disorders that proceed physical signs and symptoms [17]. The term cerebrovascular function has been used broadly to encompass resting levels of CBF, cerebrovascular conductance (CBF/mean arterial blood pressure (MAP)), cerebrovascular resistance (MAP/CBF), and indices of CBF regulation [18]. The regulation of CBF is characterized within the literature in several ways. Cerebrovascular reactivity characterizes the CBF response to changes in carbon dioxide (CO2), whereby cerebral vessels should vasodilate and increase CBF with elevated levels of arterial CO2 (hypercapnia); and vasoconstrict and decrease CBF with reduced levels of arterial CO2 (hypocapnia) [13,19]. Neurovascular coupling involves CBF response to changes in neural activity (e.g., visual stimuli, cognitive tasks) [20,21]. Within each neurovascular unit, modulations in neuronal activity alter the smooth muscle vascular tone and local blood flow either directly or mediated through the astrocyte glial cell within the unit [21]. Cerebral autoregulation is defined as the intrinsic ability to maintain CBF in response to changes in perfusion pressure, predominately influenced by arterial blood pressure [19]. While there has been extensive debate regarding the understanding of cerebral autoregulation in humans, contemporary views promote further characterization as static autoregulation based on CBF response under steady-state conditions (e.g., >10 min); or dynamic autoregulation based on CBF response to spontaneous (resting) or induced (e.g., Valsalva, sit-to-stand, exercise) fluctuations in blood pressure [22,23]. Finally, there appears to be a systemic regulation of CBF with changes in cardiac output, independent of changes in arterial blood pressure [24,25,26]. Non-neural flow-mediated regulatory mechanisms have been suggested, whereby changes in pulsatile flow and shear stress alter nitric oxide release or endothelin production, which in turn influences cerebrovascular resistance and CBF [27].

3. Cardiovascular Disease and Brain Health

Several studies have shown that the risk of cognitive impairment is increased for patients with CVD or HF [7,8,28,29]. Meta-analyses have estimated the risk of cognitive impairment is 62% higher in HF and 45% higher in coronary heart disease [7]. The Women’s Health Initiative Study found in postmenopausal women, that those with a previous myocardial infarction had the greatest risk of cognitive impairment (HR: 2.10, 95%CI: 1.40–3.15) compared with any CVD (HR: 1.29, 95%CI: 1.00–1.67) [29]. Furthermore, the Swedish Twin Study showed that increased risk of cognitive decline with CVD is not isolated to vascular-related dementias, with CVD doubling the risk of Alzheimer’s disease in adults with genotype predisposition (APOE4 allele carriers) [30].
Dementia and CVD share common risk factors (such as hypertension, adiposity, hyperlipidemia, and diabetes mellitus), that have adverse effects on vascular structure and function [31]. Hypertension and obesity are both associated with hyperactivity of the sympathetic nervous system [32,33], which can result in excessive vascular resistance, arterial stiffness, and adverse cerebrovascular remodelling [34]. Excess adiposity, hyperlipidemia, and hyperglycemia also adversely affect the vasculature and brain through inflammatory pathways [35,36]. Inflammation and oxidative stress damages the endothelial cell layer [31], which through release of nitric oxide, plays an important role in vascular function and maintaining the integrity of the brain blood barrier [37,38,39]. Alterations in vascular structure and tone can modify cerebral hemodynamics and lead to chronic reductions in CBF, disrupted regulation of CBF, and impaired protein clearance [40,41]. Adequate CBF is important for maintaining the integrity of the blood brain barrier. Cerebral hypoperfusion, and subsequently reduced oxygen and glucose to the brain, can negatively affect the endothelial and neighboring cells within the neurovascular unit [40,42]. Reduced glucose to the brain can induce excitotoxicity and cause metabolism disruption, mitochondrial dysfunction, activation of proteases/phospholipases, and production of reactive oxidative species, which collectively disrupt blood brain barrier integrity through cell membrane damage and vascular cell death [42]. Breakdown of the blood brain barrier can make neurons susceptible to damage by facilitating the entry of neurotoxic compounds and pathogens that initiate neurodegenerative pathways [43]. Reductions in cardiac function, which decreases cardiac output and systemic perfusion, may also contribute to cerebral hypoperfusion and cognitive impairment [44]. The relationship between cardiac output and middle cerebral artery blood velocity (MCAv) appears to be linear [26,45]. The extent of CBF reduction in patients with HF has been shown to correlate with disease severity [46], and increases in MCAv have been found with improvement in left ventricular ejection fraction following cardiac resynchronization therapy [47]. Although, Hammond et al. [10] found that cognitive decline was similar in HF patients with reduced versus preserved ejection fraction. In HF patients with preserved ejection fraction, the mechanisms for cognitive decline are likely related to obesity, vascular impairment, diastolic dysfunction, chronic neurohormonal activation [48].
Large artery stiffening is another link between CVD and the brain. Arterial stiffness and wave reflection (the reflection of the pressure pulse wave back to the heart), increases pulse pressure and pulsatile blood flow to the smaller vessels of the arterial tree (notably the brain) [49]. This increased pulse pressure contributes to microvascular pulsatility and hemodynamic stress within the perivascular spaces of the brain, that results in microstructural damage and impairments in β-amyloid clearance [50]. Arterial stiffness is a common cause of cerebral small vessel disease, which affect the arteries, arterioles, capillaries, and veins within the brain [51]. Two common types of cerebral small vessel disease include (1) arteriosclerosis (referred to as arterial stiffening or hypertensive small vessel disease), characterized by the loss of smooth muscle cells, narrowing of the lumen, and thickening of the vessel walls; and (2) cerebral amyloid angiopathy, characterized by the progressive accumulation of β-amyloid protein [51]. This damage to the cerebral vessels can cause ischemia, inflammation, vessel rupture, and disruption of the brain-blood barrier and neural connectivity pathways, that results in pathological brain changes such as white matter hyperintensities, lacunar infarcts, microbleeds, and macroscopic hemorrhage [51,52].
Coronary artery bypass graft surgery (CABG) has been proposed to increase risk of cognitive decline due to intraoperative hypotension, hypoxia, microembolism, and/or inflammatory processes [53]. However, a study by Sweet et al. [54] compared patients following CABG or percutaneous coronary intervention (PCI) with healthy controls, and found a similar degree of decline on neurocognitive tests for both CABG and PCI over 3-weeks, 4-months, and 12-months. Furthermore, Selnes and colleagues conducted an expert review of the topic and concluded ‘the extent of pre-existing cerebrovascular and systemic vascular disease’ have a greater effect than procedural variables on neurocognitive function in the short- and long-term [55].

4. Mechanisms for Improving Brain Health with Exercise

There is substantial evidence that exercise training is an effective way to increase cardiorespiratory fitness [56], improve vascular structure and function [38,57], and reduce traditional CVD risk factors and inflammation [58,59]. Moreover, there is accumulating evidence that moderate-vigorous exercise training improves cognitive function, particularly in areas of attention-psychomotor function, executive function, and memory [60,61]. Higher cardiorespiratory fitness, as peak oxygen uptake (peak VO2), has been associated with higher cognitive function [62], attenuation of gray matter volume atrophy [31,63], greater white matter integrity [64], and higher MCAv and cerebrovascular function [62,65,66]. Furthermore, maintaining or increasing cardiorespiratory fitness over time has been shown to reduce the risk of dementia incidence and mortality [67].
While normal aging is associated with a decline in resting levels of CBF, habitual exercisers with higher cardiorespiratory fitness have been shown to have higher resting MCAv levels than age-matched sedentary counterparts [66]. Proposed mechanisms for this involve exercise-induced increases in the recruitment and/or new growth of capillaries (i.e., angiogenesis), as well as beneficial vascular remodelling from repetitive hemodynamic forces on the artery walls (i.e., shear-stress) that occurs with exercise [38,68]. A recent meta-analysis by Smith et al. [18], found no change in resting MCAv with exercise training interventions (2–7 months duration) compared with control. Although, seven of the eight included studies did not measure changes in cerebrovascular conductance index (i.e., MCAv/MAP), which would account for potential changes in arterial blood pressure with exercise training. In contrast, results from The Brain in Motion Study (n = 206 healthy middle-aged adults) [69] showed 6-months of moderate intensity aerobic training significantly improved resting MCAv and reduced cerebrovascular resistance in conjunction with improvements in cognitive functions. Furthermore, Tomoto et al. [70] showed 12-months of moderate-vigorous aerobic training increased total CBF (normalized for total brain mass) and reduced cerebral pulsatility in patients with mild cognitive impairment, which were associated with changes in peak VO2.
The effect of habitual exercise and cardiorespiratory fitness on cerebrovascular function has also been studied, by assessing cerebrovascular reactivity (i.e., changes in CBF or MCAv with changes in arterial CO2). Similar to resting CBF or MCAv, cerebrovascular reactivity decreases with age [13], however higher levels of habitual exercise and cardiorespiratory fitness are associated with greater cerebrovascular reactivity [71,72]. Furthermore, several studies have shown aerobic exercise training (compared with control), can improve cerebrovascular reactivity in middle-aged healthy adults [73], stroke survivors [74], and breast cancer survivors (high intensity group) [75]. Concomitantly, two of these studies demonstrated substantial improvements in peak VO2 (~19%) [74,75], and Ivey et al. [74] found a positive correlation (r = 0.55) between changes in peak VO2 and changes in cerebrovascular reactivity. In contrast, The Brain in Motion Study [69] found no improvement in cerebrovascular reactivity with 6-months of moderate intensity aerobic training. This study showed a significant, but small improvement in peak VO2 (~7%). Therefore, substantial improvements in cardiorespiratory fitness (as peak VO2) may be necessary for eliciting changes in cerebrovascular reactivity. Although, a study by Thomas et al. [76] found cerebrovascular reactivity was reduced in elderly Masters athletes compared with elderly sedentary males. The authors suggested the lower cerebrovascular reactivity may be related to vascular desensitization from chronic exposure to higher CO2 levels with exercise training [76]. Over a short-term period, we have found no effect of repeated hypercapnia (CO2) exposures on cerebrovascular reactivity in healthy adults [77].
Higher levels of cardiorespiratory fitness have also been positively associated with volumes of gray matter and white matter in older adults, specifically the attenuation of the age-related atrophy rates in the frontal, temporal, and parietal regions [63,78]. Therefore, exercise may contribute to a greater ‘reserve’ or threshold against the clinical manifestations of cognitive impairment. This concept of ‘reserve’ emerged due to individual differences in the susceptibility of cognitive impairment as well as discontinuity between cognitive outcomes and neuropathology (e.g., β-amyloid burden & neurofibrillary tangles of Tau) [31,79]. Stern [80] discusses the concept of ‘brain reserve’, whereby individuals with greater brain volumes may tolerate higher levels of neuropathology without affecting cognitive function; and ‘cognitive reserve’ whereby cognitively normal adults tolerate a higher level of neuropathology through pre-existing cognitive processes or compensatory approaches [80]. Exercise and stimulating environments may contribute to brain and cognitive reserve through the upregulation of neurotrophic growth factors such as brain-derived neurotrophic factor and insulin-like growth factor, which promote neurogenesis (i.e., the formation and maintenance of neurons) and neuroplasticity (i.e., the improvement of brain structure and function) [81,82]. While life-long exercise and higher levels of cardiorespiratory fitness are associated with less atrophy of gray matter volumes, the evidence for exercise training increasing gray matter volumes is less convincing and may be specific to the left hippocampus region [83].

5. Effect of Exercise Training on Brain Health in CVD

Previous reviews that have investigated the effect of cardiac rehabilitation on cognitive function [53,84] have found promising but limited evidence for exercise-based cardiac rehabilitation on cognitive function. A literature search of MEDLINE and Scopus was recently conducted by Taylor [85] identifying fourteen exercise training studies in patients with CVD and/or HF assessing brain-related outcomes (i.e., cognitive function, CBF, cerebral artery blood velocity, cerebrovascular function, and brain imaging markers). A summary of the study characteristics and brain-related outcomes for thirteen chronic exercise training studies (≥14 days) are outlined in Table 1. One study by Anazodo et al. published their results as two manuscripts including outcomes of cognitive function and brain structure [15] and CBF [14]. Twelve of thirteen exercise training studies were performed within a cardiac rehabilitation setting. Cardiac rehabilitation is internationally recognized as a class 1A recommendation for patients following a cardiovascular-related event or procedure, which promotes intensive CVD risk factor modification and exercise training [86,87].

5.1. Cognitive Function

Twelve of the thirteen studies assessed cognitive function [14,15,88,89,90,91,92,93,94,95,96,97,98] (Table 1). Six of nine studies found a significant improvement in global cognitive function, using the Montreal Cognitive Assessment (MoCA) [93,98], Mini-Mental State Examination (MMSE) [95] Modified MMSE [90], Functional Independence Cognitive Measure [97], and NIH Toolbox Fluid Composite Score [96]. Seven of eight studies showed improvements in at least one test related to attention-psychomotor function [88,89,90,91,92,95,96]. Only Lee et al. [94] found no improvement in attention-psychomotor function. Three of seven studies showed improvements in executive function [88,95,96], while four studies found no improvement [90,91,92,94] (Table 1). Three of five studies found an improvement in verbal memory [90,91,92] while two studies found no change [94,96]. Two of four studies showed an improvement in visuospatial working memory [90,96] and two studies showed no change [88,92] (Table 1). Finally, none of the five studies assessing language with verbal fluency or naming tests showed a significant effect of exercise training [88,89,90,91,92]. Taken together, the current evidence suggests exercise training in patients with CVD or HF improves global cognitive function and attention-psychomotor function but not language processes [85]. The effect of exercise training on executive functions and memory in patients with CVD or HF is less clear with conflicting results between studies [85].
Taylor [85] reported a major limitation within the available studies is the lack of a control group, and therefore it cannot be determined whether improvements in cognition following a cardiac-related event would occur naturally without exercise training or could be from learning effects related to the cognitive tests. Stanek et al. [90] found improvements in attention-psychomotor function and verbal memory exceeded those of practice effects but improvements in global and executive function were similar to practice effects. Tanne et al. [88] found significant improvements in measures of psychomotor and executive functions compared with controls that could not complete the exercise training intervention, but no differences for improvements in global function (MMSE) or other neurocognitive tests. Finally, Fujiyoshi and colleagues [95] found patients attending monthly cardiac rehabilitation over 6-months had significantly greater improvements in global cognition and executive function than patients attending less than monthly cardiac rehabilitation as a control group.
From the available studies it is difficult to determine whether intensity of the exercise interventions plays a role in improving cognitive functions. Six of the thirteen studies did not report details of exercise intensity. However, the majority of included studies reported significant improvements in exercise capacity for the exercise groups (Table 1). Furthermore, several studies reported significant correlations between change in exercise capacity and change in cognitive domains, including change in peak metabolic equivalents (METs) and attention-executive function [89], change in peak METs and verbal memory [90], and change in submaximal test METs and working memory [96]. The two studies that found no improvement in cognition, also found no significant improvements in peak VO2 [15,94].

5.2. Brain Structure and Cerebrovascular Function

The effect of exercise training on brain structure was only measured by one study [15]. Using magnetic resonance imaging (MRI), Anazodo et al. [15] found significant bilateral improvements in gray matter volume within the frontal lobe, middle temporal gyrus, supplementary motor area during cardiac rehabilitation, which were areas that showed significant atrophy compared with healthy controls at baseline. One study investigated the effect of exercise training on CBF using MRI arterial spin labelling [14], and three studies measured the effect on cerebral artery blood velocity using transcranial doppler ultrasound (TCD) [88,90,99]. One study also used near-infrared spectroscopy as a marker of cerebral oxygenation [96]. In the same MRI study above, Anazodo et al. [14] found significant improvements in regional gray matter CBF bilaterally within the Anterior Cingulate by 30%, but no significant change in global CBF. Of note, the Anterior Cingulate lies within the medial aspect of the frontal lobe and is known to have an important role in executive functions relating to emotional control, focused problem-solving, error recognition, and adaptive responses to changing conditions [100]. Using TCD, none of the three studies [88,90,99] found a significant change in resting MCAv, and Smith et al. [99] found a decrease in resting posterior cerebral artery velocity (PCAv). However, Stanek et al. [90] found a significant improvement in resting anterior cerebral artery velocity (ACAv). Notably, the ACA branches into the pericallosal artery to supply CBF to the Anterior Cingulate [101], where Anazodo et al. [14] found a significant increase in CBF. Stanek et al. [90] also found that higher ACAv and MCAv at baseline was associated with greater improvements in visuospatial working memory.
In terms of cerebrovascular regulation, Tanne et al. [88] measured MCAv cerebrovascular reactivity with TCD using a breath-hold index and found no significant improvements in either the exercise group or control. It is intriguing that this study found improvements in cardiovascular hemodynamics (cardiac index and systemic vascular resistance) but this did not translate into improvements in MCAv or cerebrovascular reactivity in patients with HF [88]. This study also demonstrated significant improvements in exercise capacity with 6-min walk test and treadmill METs, however changes in cardiorespiratory fitness as peak VO2 were not directly measured. Smith et al. [99] measured cerebrovascular regulation during submaximal and maximal exercise before and after 12-weeks of exercise-based cardiac rehabilitation in patients with left ventricular assist devices (LVADs). Despite a reduction in resting PCAv following exercise training, patients with LVAD achieved greater increases in PCAv during submaximal and maximal exercise, compared with before training. Similarly, following exercise training patients had higher flow through the internal carotid artery during submaximal exercise, although this did not lead to improved regulation of MCAv. Overall, there is very limited evidence available assessing the effect of exercise training on brain structure and cerebrovascular function in patients with CVD.

6. Is There Rationale for Higher Intensity Exercise?

The magnitude of change in cardiorespiratory fitness [89,90,96] and vascular function [102] during cardiac rehabilitation has been shown to significantly correlate with changes in cognitive function. High intensity interval training (HIIT) is a potent stimulus for improving cardiorespiratory fitness (as peak VO2) and vascular function compared with moderate intensity continuous training (MICT) [103,104,105]. Importantly, the superior effects of HIIT on peak VO2 and vascular function compared with MICT also occurs in patients with CVD [106,107,108,109], and HIIT has been shown to be safe and feasible in patients attending cardiac rehabilitation [110,111,112]. Furthermore, in patients with HF, HIIT has shown greater improvements in cardiac function compared with MICT [106,113]. Therefore, we propose that greater improvements in cardiorespiratory fitness, vascular function, and cardiac perfusion with HIIT, has potential to translate into greater adaptations for cerebrovascular health and cognitive function (see Figure 1).
HIIT involves alternating bouts of high intensity exercise interspersed with bouts of active or passive recovery. Various protocols of HIIT have been studied in clinical and healthy populations, ranging from short-duration HIIT protocols (work intervals < 1-min), medium-duration HIIT protocols (work intervals 1–3 min), and long-duration HIIT protocols (work intervals ≥ 3 min) [114,115]. Furthermore, HIIT protocols accumulating ≥ 15-min of high intensity exercise in total have been defined as high-volume HIIT [105]. HIIT should not be confused with sprint interval training, which instead involves brief maximal or supramaximal efforts (≥100% peak oxygen uptake or work capacity) typically with shorter work intervals than HIIT and a greater proportion of recovery time [103]. A well-known example of a high-volume HIIT protocol is the 4x4 Norwegian protocol involving four bouts of 4-min high intensity intervals (at ~85–95% of peak heart rate; hard to very hard effort) interspersed with 3-min lower intensity recovery intervals (at ~60–70% of peak heart rate; fairly light effort) [109,116,117,118]. High-volume HIIT protocols have demonstrated superior improvements on health outcomes compared with MICT (particularly for peak VO2) while low-volume HIIT protocols typically show comparable improvements with MICT [105,115]. A HIIT protocol can be applied to various forms of exercise based on an individual’s preference and capabilities, such as walking hills, jogging, cycling, rowing ergometer, elliptical, swimming, or aerobics/dance [119].
A proposed mechanism for the superior effect of HIIT on peripheral vascular function, when compared with MICT, is that higher intensity exercise provokes greater blood flow and shear stress stimulus that allows for greater vascular adaptation and upregulation of vasodilatory prostaglandins [13,38] and nitric oxide [38,120]. While this evidence has emerged mainly from studies of the forearm artery [104], it is reasonable to infer that greater shear stress and therefore vascular adaptation, would also occur in the cerebral vasculature. Indeed, Ogoh et al. [121] showed significantly higher internal carotid artery velocity (i.e., shear stress) for HIIT compared with MICT during acute exercise and recovery. Moreover, Klein et al. [122] found significantly greater total MCAv (i.e., shear stress) during an acute bout of HIIT compared with MICT for younger and older adults. Historically our understanding of CBF changes with cycle exercise has involved an inverted U-shape pattern, whereby MCAv and internal carotid artery flow increases with exercise intensity to ~60% of maximal VO2 and then decreases toward baseline levels with higher intensities due to hyperventilation-induced hypocapnia (reduced CO2) and cerebral vasoconstriction [123]. Therefore, exercise at higher intensities seemed counterintuitive to increasing CBF and shear stress within the cerebral circulation [124]. However, combining intervals of high intensity exercise with short intervals of active recovery (i.e., HIIT) appears to lead to a greater accumulation of CBF and shear stress than MICT [121,122]. Furthermore, studies examining MCAv during rowing exercise [125] and running [126] have shown that MCAv may not exhibit the same inverted U-shape pattern as cycling exercise. With running, Furlong et al. [126] showed a continual increase in MCAv across the full range of intensities up to 95% VO2max, compared with the usual inverted U-shape pattern for cycling (peaking at 65% VO2max). Faull et al. [125] found similar patterns of MCAv response with increasing intensities of rowing exercise, although this was not compared with cycling exercise. Taken together, these studies suggest acute bouts of higher intensity exercise provide a greater dose of shear stress, that may promote greater cerebrovascular adaptations with exercise training.
There are no published studies examining the effect of HIIT on cerebrovascular outcomes in patients with CVD. In non-cardiac populations, Whittaker et al. [127] conducted a systematic review on the acute and chronic effects of HIIT on cerebrovascular outcomes. Only three studies assessed the chronic effect of HIIT on cerebrovascular outcomes, including cerebral oxygenation using NIRS in healthy older adults [128], dynamic cerebral autoregulation in endurance training males [129], and cerebrovascular reactivity in breast cancer survivors [75]. Overall, none of the studies found a significant interaction effect between time and exercise intensity on any cerebrovascular outcomes, however it should be highlighted that all studies were small and not adequately powered to detect significant differences between groups. The pilot study by Northey et al. [75] in breast cancer survivors showed that 12-weeks of HIIT resulted in moderate-large positive effects on resting MCAv (effect size (ES) = 0.86) and MCAv cerebrovascular reactivity (ES = 0.72) compared with control, and a moderate effect on MCAv cerebrovascular reactivity (ES = 0.54) compared with MICT. Drapeau et al. [129] found a subtle reduction in dynamic cerebral autoregulation after 6-weeks of HIIT in endurance training athletes, although there was no comparison to a moderate intensity group or control group.
To date, only one study by Lee et al. [94] has compared the effect of HIIT and MICT on cognitive function during cardiac rehabilitation and found no significant improvement in either group for any cognitive domains (Table 1). Although, recruitment and retention challenges resulted in a small sample size (n = 7 per group) which was underpowered to detect differences between groups. This study also found no significant group differences for peak VO2 improvement between HIIT and MICT despite using a high-volume 4 × 4-min HIIT protocol (i.e., greater dose than MICT); and the improvement in peak VO2 with HIIT (1.3 mL/kg/min) was 3-fold lower in comparison to the peak VO2 improvements with HIIT in other studies involving patients with coronary artery disease (mean = 4.6 mL/kg/min) [106]. A reason for this may be that most of the exercise training was performed in a home-based setting with one supervised exercise session per week. Several small studies have compared HIIT and MICT on cognitive function in non-cardiac populations. A study in older adults [130] found improvement in working memory with 12-weeks of HIIT but not MICT. In younger adults [131], 6-weeks of HIIT but not MICT showed improvement in executive function response time. The pilot study by Northey et al. [75] comparing HIIT and MICT with no-exercise control in breast cancer survivors, found moderate-large positive effects for HIIT in comparison to MICT for executive function (ES = 0.55) and working memory (ES = 1.41) and in comparison to no-exercise control for episodic working (ES = 0.76), executive function (ES = 0.75), and working memory (ES = 0.81). Of note, the improvement in peak VO2 significantly increased with HIIT (19%) but not MICT (6%) or control (3%), which supports the notion that the stimulus of the intervention on cardiorespiratory fitness is likely important for changes in cognitive functions and cerebrovascular outcomes. More studies are needed comparing exercise of different intensities on measures of cognitive function, cerebrovascular outcomes, and brain structure.

7. Conclusions

Patients with CVD and HF are at increased risk of cognitive decline. Exercise training, predominantly during cardiac rehabilitation, consistently shows improvements in global and attention-psychomotor cognitive functions, but the effect on executive function and memory is less clear. Although, an important caveat is the lack of control groups and therefore cannot be definitive that improvements did not occur from practice effects or naturally with time following a cardiac event. However, the degree of cardiorespiratory fitness improvement with exercise training appears to be an important mediator (or marker of adequate training stimulus) for changes in cognitive function and cerebrovascular outcomes in healthy and clinical populations. Since HIIT is a potent stimulus for improving cardiorespiratory fitness, this supports the hypothesis that HIIT may also promote superior improvements in cognitive function and cerebrovascular outcomes. Furthermore, the greater accumulation of CBF and shear stress during HIIT compared to MICT, may allow for greater vascular adaptations and improvements in cerebrovascular outcomes and cognitive function. Currently, there is a very limited amount of research investigating the influence of exercise training intensity on cognitive function and cerebrovascular outcomes, and there are no studies in CVD or HF populations. Well-designed exercise training studies are warranted to investigate the effect of HIIT on cognitive function and cerebrovascular outcomes in patients with CVD and HF; and determine the optimal exercise prescription for improving brain health in this high-risk population.

Author Contributions

All authors contributed to Conceptualization. J.L.T. contributed to Writing—Original Draft Preparation. J.N.B. and B.D.J. contributed to Writing—Review and Editing. All authors have read and agreed to the published version of the manuscript.

Funding

J.L.T. is supported by the National Institute on Health (1R21AG073726). J.N.B. is supported by the National Institute on Health (1RF1NS117746 and AG070469).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Petersen, R.C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 2004, 256, 183–194. [Google Scholar] [CrossRef]
  2. Prince, M.; Wimo, A.; Guerchet, M.; Ali, G.C.; Wu, Y.T.; Prima, M. World Alzheimer Report 2015—The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends; Alzheimer’s Disease International: London, UK, 2015. [Google Scholar]
  3. Albert, M.S.; DeKosky, S.T.; Dickson, D.; Dubois, B.; Feldman, H.H.; Fox, N.C.; Gamst, A.; Holtzman, D.M.; Jagust, W.J.; Petersen, R.C.; et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011, 7, 270–279. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Norton, S.; Matthews, F.E.; Barnes, D.E.; Yaffe, K.; Brayne, C. Potential for primary prevention of Alzheimer’s disease: An analysis of population-based data. Lancet Neurol. 2014, 13, 788–794. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Roth, G.A.; Johnson, C.; Abajobir, A.; Abd-Allah, F.; Abera, S.F.; Abyu, G.; Ahmed, M.; Aksut, B.; Alam, T.; Alam, K.; et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J. Am. Coll. Cardiol. 2017, 70, 1–25. [Google Scholar] [CrossRef]
  6. Virani Salim, S.; Alonso, A.; Benjamin Emelia, J.; Bittencourt Marcio, S.; Callaway Clifton, W.; Carson April, P.; Chamberlain Alanna, M.; Chang Alexander, R.; Cheng, S.; Delling Francesca, N.; et al. Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association. Circulation 2020, 141, e139–e596. [Google Scholar]
  7. Deckers, K.; Schievink, S.H.J.; Rodriquez, M.M.F.; van Oostenbrugge, R.J.; van Boxtel, M.P.J.; Verhey, F.R.J.; Köhler, S. Coronary heart disease and risk for cognitive impairment or dementia: Systematic review and meta-analysis. PLoS ONE 2017, 12, e0184244. [Google Scholar] [CrossRef] [PubMed]
  8. Roberts, R.O.; Geda, Y.E.; Knopman, D.S.; Cha, R.H.; Pankratz, V.S.; Boeve, B.F.; Tangalos, E.G.; Ivnik, R.J.; Mielke, M.M.; Petersen, R.C. Cardiac disease associated with increased risk of nonamnestic cognitive impairment: Stronger effect on women. JAMA Neurol. 2013, 70, 374–382. [Google Scholar] [CrossRef] [Green Version]
  9. Xie, W.; Zheng, F.; Yan, L.; Zhong, B. Cognitive Decline Before and After Incident Coronary Events. J. Am. Coll. Cardiol. 2019, 73, 3041. [Google Scholar] [CrossRef] [PubMed]
  10. Hammond Christa, A.; Blades Natalie, J.; Chaudhry Sarwat, I.; Dodson John, A.; Longstreth, W.T.; Heckbert Susan, R.; Psaty Bruce, M.; Arnold Alice, M.; Dublin, S.; Sitlani Colleen, M.; et al. Long-Term Cognitive Decline After Newly Diagnosed Heart Failure. Circ. Heart Fail. 2018, 11, e004476. [Google Scholar] [CrossRef]
  11. Wolters Frank, J.; Zonneveld Hazel, I.; Hofman, A.; van der Lugt, A.; Koudstaal Peter, J.; Vernooij Meike, W.; Ikram, M.A. Cerebral Perfusion and the Risk of Dementia. Circulation 2017, 136, 719–728. [Google Scholar] [CrossRef] [Green Version]
  12. Lu, H.; Xu, F.; Rodrigue, K.M.; Kennedy, K.M.; Cheng, Y.; Flicker, B.; Hebrank, A.C.; Uh, J.; Park, D.C. Alterations in cerebral metabolic rate and blood supply across the adult lifespan. Cereb. Cortex 2011, 21, 1426–1434. [Google Scholar] [CrossRef] [PubMed]
  13. Barnes, J.N.; Schmidt, J.E.; Nicholson, W.T.; Joyner, M.J. Cyclooxygenase inhibition abolishes age-related differences in cerebral vasodilator responses to hypercapnia. J. Appl. Physiol. 2012, 112, 1884–1890. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Anazodo, U.C.; Shoemaker, J.K.; Suskin, N.; Ssali, T.; Wang, D.J.J.; St Lawrence, K.S. Impaired Cerebrovascular Function in Coronary Artery Disease Patients and Recovery Following Cardiac Rehabilitation. Front. Aging Neurosci. 2016, 7, 224. [Google Scholar] [CrossRef] [PubMed]
  15. Anazodo, U.C.; Shoemaker, J.K.; Suskin, N.; St Lawrence, K.S. An investigation of changes in regional gray matter volume in cardiovascular disease patients, pre and post cardiovascular rehabilitation. Neuroimage Clin. 2013, 3, 388–395. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Lloyd-Jones, D.M.; Leip, E.P.; Larson, M.G.; D’Agostino, R.B.; Beiser, A.; Wilson, P.W.; Wolf, P.A.; Levy, D. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006, 113, 791–798. [Google Scholar] [CrossRef]
  17. Sweeney, M.D.; Kisler, K.; Montagne, A.; Toga, A.W.; Zlokovic, B.V. The role of brain vasculature in neurodegenerative disorders. Nat. Neurosci. 2018, 21, 1318–1331. [Google Scholar] [CrossRef]
  18. Smith, E.C.; Pizzey, F.K.; Askew, C.D.; Mielke, G.I.; Ainslie, P.N.; Coombes, J.S.; Bailey, T.G. Effects of cardiorespiratory fitness and exercise training on cerebrovascular blood flow and reactivity: A systematic review with meta-analyses. Am. J. Physiol. Heart Circ. Physiol. 2021, 321, H59–H76. [Google Scholar] [CrossRef]
  19. Willie, C.K.; Colino, F.L.; Bailey, D.M.; Tzeng, Y.C.; Binsted, G.; Jones, L.W.; Haykowsky, M.J.; Bellapart, J.; Ogoh, S.; Smith, K.J.; et al. Utility of transcranial Doppler ultrasound for the integrative assessment of cerebrovascular function. J. Neurosci. Methods 2011, 196, 221–237. [Google Scholar] [CrossRef]
  20. Iadecola, C. The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease. Neuron 2017, 96, 17–42. [Google Scholar] [CrossRef] [Green Version]
  21. Phillips, A.A.; Chan, F.H.; Zheng, M.M.; Krassioukov, A.V.; Ainslie, P.N. Neurovascular coupling in humans: Physiology, methodological advances and clinical implications. J. Cereb. Blood Flow. Metab. 2016, 36, 647–664. [Google Scholar] [CrossRef] [Green Version]
  22. Claassen, J.; Thijssen, D.H.J.; Panerai, R.B.; Faraci, F.M. Regulation of cerebral blood flow in humans: Physiology and clinical implications of autoregulation. Physiol. Rev. 2021, 101, 1487–1559. [Google Scholar] [CrossRef] [PubMed]
  23. Brassard, P.; Labrecque, L.; Smirl, J.D.; Tymko, M.M.; Caldwell, H.G.; Hoiland, R.L.; Lucas, S.J.E.; Denault, A.Y.; Couture, E.J.; Ainslie, P.N. Losing the dogmatic view of cerebral autoregulation. Physiol. Rep. 2021, 9, e14982. [Google Scholar] [CrossRef] [PubMed]
  24. Ainslie, P.N.; Duffin, J. Integration of cerebrovascular CO2 reactivity and chemoreflex control of breathing: Mechanisms of regulation, measurement, and interpretation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296, R1473–R1495. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Secher, N.H.; Seifert, T.; Lieshout, J.J.V. Cerebral blood flow and metabolism during exercise: Implications for fatigue. J. Appl. Physiol. 2008, 104, 306–314. [Google Scholar] [CrossRef]
  26. Ogoh, S.; Brothers, R.M.; Barnes, Q.; Eubank, W.L.; Hawkins, M.N.; Purkayastha, S.; O-Yurvati, A.; Raven, P.B. The effect of changes in cardiac output on middle cerebral artery mean blood velocity at rest and during exercise. J. Physiol. 2005, 569, 697–704. [Google Scholar] [CrossRef]
  27. Zhang, R.; Levine, B.D. Autonomic Ganglionic Blockade Does Not Prevent Reduction in Cerebral Blood Flow Velocity during Orthostasis in Humans. Stroke 2007, 38, 1238–1244. [Google Scholar] [CrossRef] [Green Version]
  28. Vogels, R.L.C.; Scheltens, P.; Schroeder-Tanka, J.M.; Weinstein, H.C. Cognitive impairment in heart failure: A systematic review of the literature. Eur. J. Heart Fail. 2007, 9, 440–449. [Google Scholar] [CrossRef]
  29. Haring, B.; Leng, X.; Robinson, J.; Johnson, K.C.; Jackson, R.D.; Beyth, R.; Wactawski-Wende, J.; von Ballmoos, M.W.; Goveas, J.S.; Kuller, L.H.; et al. Cardiovascular disease and cognitive decline in postmenopausal women: Results from the Women’s Health Initiative Memory Study. J. Am. Heart Assoc. 2013, 2, e000369. [Google Scholar] [CrossRef] [Green Version]
  30. Eriksson, U.K.; Bennet, A.M.; Gatz, M.; Dickman, P.W.; Pedersen, N.L. Nonstroke cardiovascular disease and risk of Alzheimer disease and dementia. Alzheimer Dis. Assoc. Disord. 2010, 24, 213–219. [Google Scholar] [CrossRef] [Green Version]
  31. Barnes, J.N. Exercise, cognitive function, and aging. Adv. Physiol. Educ. 2015, 39, 55–62. [Google Scholar] [CrossRef] [Green Version]
  32. Mancia, G.; Grassi, G. The Autonomic Nervous System and Hypertension. Circ. Res. 2014, 114, 1804–1814. [Google Scholar] [CrossRef] [PubMed]
  33. Joyner, M.J.; Charkoudian, N.; Wallin, B.G. A sympathetic view of the sympathetic nervous system and human blood pressure regulation. Exp. Physiol. 2008, 93, 715–724. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Bruno, R.M.; Ghiadoni, L.; Seravalle, G.; Dell’oro, R.; Taddei, S.; Grassi, G. Sympathetic regulation of vascular function in health and disease. Front. Physiol. 2012, 3, 284. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Stillman, C.M.; Weinstein, A.M.; Marsland, A.L.; Gianaros, P.J.; Erickson, K.I. Body–Brain Connections: The Effects of Obesity and Behavioral Interventions on Neurocognitive Aging. Front. Aging Neurosci. 2017, 9, 115. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Eckel, R.H.; Alberti, K.; Grundy, S.M.; Zimmet, P.Z. The metabolic syndrome. Lancet 2010, 375, 181–183. [Google Scholar] [CrossRef] [PubMed]
  37. Furchgott, R.F.; Zawadzki, J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288, 373–376. [Google Scholar] [CrossRef]
  38. Green, D.J.; Hopman, M.T.; Padilla, J.; Laughlin, M.H.; Thijssen, D.H. Vascular Adaptation to Exercise in Humans: Role of Hemodynamic Stimuli. Physiol. Rev. 2017, 97, 495–528. [Google Scholar] [CrossRef]
  39. Takeda, S.; Sato, N.; Morishita, R. Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: Relevance to pathogenesis and therapy. Front. Aging Neurosci. 2014, 6, 171. [Google Scholar] [CrossRef] [Green Version]
  40. de la Torre, J.C. Critical threshold cerebral hypoperfusion causes Alzheimer’s disease? Acta Neuropathol. 1999, 98, 1–8. [Google Scholar] [CrossRef]
  41. Walker, K.A.; Power, M.C.; Gottesman, R.F. Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: A Review. Curr. Hypertens. Rep. 2017, 19, 24. [Google Scholar] [CrossRef]
  42. Rajeev, V.; Fann, D.Y.; Dinh, Q.N.; Kim, H.A.; De Silva, T.M.; Lai, M.K.P.; Chen, C.L.; Drummond, G.R.; Sobey, C.G.; Arumugam, T.V. Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment. Theranostics 2022, 12, 1639–1658. [Google Scholar] [CrossRef]
  43. Sweeney, M.D.; Sagare, A.P.; Zlokovic, B.V. Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 2018, 14, 133–150. [Google Scholar] [CrossRef]
  44. Fraser, K.S.; Heckman, G.A.; McKelvie, R.S.; Harkness, K.; Middleton, L.E.; Hughson, R.L. Cerebral Hypoperfusion Is Exaggerated With an Upright Posture in Heart Failure: Impact of Depressed Cardiac Output. JACC Heart Fail. 2015, 3, 168–175. [Google Scholar] [CrossRef] [PubMed]
  45. Meng, L.; Hou, W.; Chui, J.; Han, R.; Gelb, A.W. Cardiac Output and Cerebral Blood Flow: The Integrated Regulation of Brain Perfusion in Adult Humans. Anesthesiology 2015, 123, 1198–1208. [Google Scholar] [CrossRef] [PubMed]
  46. Choi, B.R.; Kim, J.S.; Yang, Y.J.; Park, K.M.; Lee, C.W.; Kim, Y.H.; Hong, M.K.; Song, J.K.; Park, S.W.; Park, S.J.; et al. Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am. J. Cardiol. 2006, 97, 1365–1369. [Google Scholar] [CrossRef]
  47. van Bommel, R.J.; Marsan, N.A.; Koppen, H.; Delgado, V.; Borleffs, C.J.W.; Ypenburg, C.; Bertini, M.; Schalij, M.J.; Bax, J.J. Effect of Cardiac Resynchronization Therapy on Cerebral Blood Flow. Am. J. Cardiol. 2010, 106, 73–77. [Google Scholar] [CrossRef] [PubMed]
  48. Yang, M.; Sun, D.; Wang, Y.; Yan, M.; Zheng, J.; Ren, J. Cognitive Impairment in Heart Failure: Landscape, Challenges, and Future Directions. Front. Cardiovasc. Med. 2022, 8, 831734. [Google Scholar] [CrossRef] [PubMed]
  49. O’Rourke, M.F.; Hashimoto, J. Mechanical Factors in Arterial Aging: A Clinical Perspective. J. Am. Coll. Cardiol. 2007, 50, 1–13. [Google Scholar] [CrossRef] [Green Version]
  50. Roos, A.d.; Grond, J.v.d.; Mitchell, G.; Westenberg, J. Magnetic Resonance Imaging of Cardiovascular Function and the Brain. Circulation 2017, 135, 2178–2195. [Google Scholar] [CrossRef] [Green Version]
  51. Pantoni, L. Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010, 9, 689–701. [Google Scholar] [CrossRef]
  52. Qiu, C.; Fratiglioni, L. A major role for cardiovascular burden in age-related cognitive decline. Nat. Rev. Cardiol. 2015, 12, 267–277. [Google Scholar] [CrossRef] [PubMed]
  53. Alagiakrishnan, K.; Mah, D.; Gyenes, G. Cardiac rehabilitation and its effects on cognition in patients with coronary artery disease and heart failure. Expert Rev. Cardiovasc. Ther. 2018, 16, 645–652. [Google Scholar] [CrossRef] [PubMed]
  54. Sweet, J.J.; Finnin, E.; Wolfe, P.L.; Beaumont, J.L.; Hahn, E.; Marymont, J.; Sanborn, T.; Rosengart, T.K. Absence of cognitive decline one year after coronary bypass surgery: Comparison to nonsurgical and healthy controls. Ann. Thorac. Surg. 2008, 85, 1571–1578. [Google Scholar] [CrossRef] [PubMed]
  55. Selnes, O.A.; Gottesman, R.F.; Grega, M.A.; Baumgartner, W.A.; Zeger, S.L.; McKhann, G.M. Cognitive and Neurologic Outcomes after Coronary-Artery Bypass Surgery. N. Engl. J. Med. 2012, 366, 250–257. [Google Scholar] [CrossRef] [PubMed]
  56. Kaminsky, L.A.; Arena, R.; Ellingsen, Ø.; Harber, M.P.; Myers, J.; Ozemek, C.; Ross, R. Cardiorespiratory fitness and cardiovascular disease—The past, present, and future. Prog. Cardiovasc. Dis. 2019, 62, 86–93. [Google Scholar] [CrossRef] [PubMed]
  57. Joyner, M.J.; Green, D.J. Exercise protects the cardiovascular system: Effects beyond traditional risk factors. J. Physiol. 2009, 587, 5551–5558. [Google Scholar] [CrossRef] [PubMed]
  58. Thompson Paul, D.; Buchner, D.; Piña Ileana, L.; Balady Gary, J.; Williams Mark, A.; Marcus Bess, H.; Berra, K.; Blair Steven, N.; Costa, F.; Franklin, B.; et al. Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease. Circulation 2003, 107, 3109–3116. [Google Scholar] [CrossRef] [Green Version]
  59. Fiuza-Luces, C.; Santos-Lozano, A.; Joyner, M.; Carrera-Bastos, P.; Picazo, O.; Zugaza, J.L.; Izquierdo, M.; Ruilope, L.M.; Lucia, A. Exercise benefits in cardiovascular disease: Beyond attenuation of traditional risk factors. Nat. Rev. Cardiol. 2018, 15, 731–743. [Google Scholar] [CrossRef]
  60. Smith, P.J.; Blumenthal, J.A.; Hoffman, B.M.; Cooper, H.; Strauman, T.A.; Welsh-Bohmer, K.; Browndyke, J.N.; Sherwood, A. Aerobic exercise and neurocognitive performance: A meta-analytic review of randomized controlled trials. Psychosom. Med. 2010, 72, 239–252. [Google Scholar] [CrossRef]
  61. Northey, J.M.; Cherbuin, N.; Pumpa, K.L.; Smee, D.J.; Rattray, B. Exercise interventions for cognitive function in adults older than 50: A systematic review with meta-analysis. Br. J. Sports Med. 2018, 52, 154. [Google Scholar] [CrossRef] [Green Version]
  62. Brown, A.D.; McMorris, C.A.; Longman, R.S.; Leigh, R.; Hill, M.D.; Friedenreich, C.M.; Poulin, M.J. Effects of cardiorespiratory fitness and cerebral blood flow on cognitive outcomes in older women. Neurobiol. Aging 2010, 31, 2047–2057. [Google Scholar] [CrossRef]
  63. Wittfeld, K.; Jochem, C.; Dörr, M.; Schminke, U.; Gläser, S.; Bahls, M.; Markus, M.R.P.; Felix, S.B.; Leitzmann, M.F.; Ewert, R.; et al. Cardiorespiratory Fitness and Gray Matter Volume in the Temporal, Frontal, and Cerebellar Regions in the General Population. Mayo Clin. Proc. 2020, 95, 44–56. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Tarumi, T.; Tomoto, T.; Repshas, J.; Wang, C.; Hynan, L.S.; Cullum, C.M.; Zhu, D.C.; Zhang, R. Midlife aerobic exercise and brain structural integrity: Associations with age and cardiorespiratory fitness. Neuroimage 2021, 225, 117512. [Google Scholar] [CrossRef] [PubMed]
  65. Bailey Damian, M.; Marley Christopher, J.; Brugniaux Julien, V.; Hodson, D.; New Karl, J.; Ogoh, S.; Ainslie Philip, N. Elevated Aerobic Fitness Sustained Throughout the Adult Lifespan Is Associated With Improved Cerebral Hemodynamics. Stroke 2013, 44, 3235–3238. [Google Scholar] [CrossRef] [Green Version]
  66. Ainslie, P.N.; Cotter, J.D.; George, K.P.; Lucas, S.; Murrell, C.; Shave, R.; Thomas, K.N.; Williams, M.J.A.; Atkinson, G. Elevation in cerebral blood flow velocity with aerobic fitness throughout healthy human ageing. J. Physiol. 2008, 586, 4005–4010. [Google Scholar] [CrossRef]
  67. Tari, A.R.; Nauman, J.; Zisko, N.; Skjellegrind, H.K.; Bosnes, I.; Bergh, S.; Stensvold, D.; Selbæk, G.; Wisløff, U. Temporal changes in cardiorespiratory fitness and risk of dementia incidence and mortality: A population-based prospective cohort study. Lancet Public Health 2019, 4, e565–e574. [Google Scholar] [CrossRef] [Green Version]
  68. Davenport, M.H.; Hogan, D.B.; Eskes, G.A.; Longman, R.S.; Poulin, M.J. Cerebrovascular Reserve: The Link Between Fitness and Cognitive Function? Exerc. Sport Sci. Rev. 2012, 40, 153–158. [Google Scholar] [CrossRef]
  69. Guadagni, V.; Drogos, L.L.; Tyndall, A.V.; Davenport, M.H.; Anderson, T.J.; Eskes, G.A.; Longman, R.S.; Hill, M.D.; Hogan, D.B.; Poulin, M.J. Aerobic exercise improves cognition and cerebrovascular regulation in older adults. Neurology 2020, 94, e2245–e2257. [Google Scholar] [CrossRef]
  70. Tomoto, T.; Liu, J.; Tseng, B.Y.; Pasha, E.P.; Cardim, D.; Tarumi, T.; Hynan, L.S.; Munro Cullum, C.; Zhang, R. One-Year Aerobic Exercise Reduced Carotid Arterial Stiffness and Increased Cerebral Blood Flow in Amnestic Mild Cognitive Impairment. J. Alzheimers Dis. 2021, 80, 841–853. [Google Scholar] [CrossRef] [PubMed]
  71. Barnes, J.N.; Taylor, J.L.; Kluck, B.N.; Johnson, C.P.; Joyner, M.J. Cerebrovascular reactivity is associated with maximal aerobic capacity in healthy older adults. J. Appl. Physiol. 2013, 114, 1383–1387. [Google Scholar] [CrossRef] [Green Version]
  72. Miller, K.B.; Howery, A.J.; Harvey, R.E.; Eldridge, M.W.; Barnes, J.N. Cerebrovascular Reactivity and Central Arterial Stiffness in Habitually Exercising Healthy Adults. Front. Physiol. 2018, 9, 1096. [Google Scholar] [CrossRef] [PubMed]
  73. Vicente-Campos, D.; Mora, J.; Castro-Piñero, J.; González-Montesinos, J.L.; Conde-Caveda, J.; Chicharro, J.L. Impact of a physical activity program on cerebral vasoreactivity in sedentary elderly people. J. Sports Med. Phys. Fitness 2012, 52, 537–544. [Google Scholar] [PubMed]
  74. Ivey, F.M.; Ryan, A.S.; Hafer-Macko, C.E.; Macko, R.F. Improved cerebral vasomotor reactivity after exercise training in hemiparetic stroke survivors. Stroke 2011, 42, 1994–2000. [Google Scholar] [CrossRef] [PubMed]
  75. Northey, J.M.; Pumpa, K.L.; Quinlan, C.; Ikin, A.; Toohey, K.; Smee, D.J.; Rattray, B. Cognition in breast cancer survivors: A pilot study of interval and continuous exercise. J. Sci. Med. Sport. 2019, 22, 580–585. [Google Scholar] [CrossRef]
  76. Thomas, B.P.; Yezhuvath, U.S.; Tseng, B.Y.; Liu, P.; Levine, B.D.; Zhang, R.; Lu, H. Life-long aerobic exercise preserved baseline cerebral blood flow but reduced vascular reactivity to CO2. J. Magn. Reson. Imaging 2013, 38, 1177–1183. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Taylor, J.L.; Lavey, J.A.; Carlson, A.R.; Barnes, J.N.; Johnson, B.D. A Pilot Study to Investigate the Effect of Hypercapnia Training on Cerebrovascular Reactivity in Healthy Adults. FASEB J. 2022, 36. [Google Scholar] [CrossRef]
  78. Colcombe, S.J.; Erickson, K.I.; Raz, N.; Webb, A.G.; Cohen, N.J.; McAuley, E.; Kramer, A.F. Aerobic fitness reduces brain tissue loss in aging humans. J. Gerontol. A Biol. Sci. Med. Sci. 2003, 58, 176–180. [Google Scholar] [CrossRef] [Green Version]
  79. Stern, Y. Cognitive reserve. Neuropsychologia 2009, 47, 2015–2028. [Google Scholar] [CrossRef]
  80. Stern, Y. Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol. 2012, 11, 1006–1012. [Google Scholar] [CrossRef] [Green Version]
  81. Stillman, C.M.; Cohen, J.; Lehman, M.E.; Erickson, K.I. Mediators of Physical Activity on Neurocognitive Function: A Review at Multiple Levels of Analysis. Front. Human Neurosci. 2016, 10, 626. [Google Scholar] [CrossRef] [Green Version]
  82. Valenzuela, P.L.; Castillo-García, A.; Morales, J.S.; de la Villa, P.; Hampel, H.; Emanuele, E.; Lista, S.; Lucia, A. Exercise benefits on Alzheimer’s disease: State-of-the-science. Ageing Res. Rev. 2020, 62, 101108. [Google Scholar] [CrossRef]
  83. Firth, J.; Stubbs, B.; Vancampfort, D.; Schuch, F.; Lagopoulos, J.; Rosenbaum, S.; Ward, P.B. Effect of aerobic exercise on hippocampal volume in humans: A systematic review and meta-analysis. Neuroimage 2018, 166, 230–238. [Google Scholar] [CrossRef]
  84. Dabbaghipour, N.; Javaherian, M.; Moghadam, B.A. Effects of cardiac rehabilitation on cognitive impairments in patients with cardiovascular diseases: A systematic review. Int. J. Neurosci. 2021, 131, 1124–1132. [Google Scholar] [CrossRef]
  85. Taylor, J.L. Exercise and the Brain in Cardiovascular Disease: A Narrative Review. Heart Mind, 2022; published online ahead of print. [Google Scholar] [CrossRef]
  86. Balady Gary, J.; Williams Mark, A.; Ades Philip, A.; Bittner, V.; Comoss, P.; Foody JoAnne, M.; Franklin, B.; Sanderson, B.; Southard, D. Core Components of Cardiac Rehabilitation/Secondary Prevention Programs: 2007 Update. Circulation 2007, 115, 2675–2682. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Ambrosetti, M.; Abreu, A.; Corrà, U.; Davos, C.H.; Hansen, D.; Frederix, I.; Iliou, M.C.; Pedretti, R.F.E.; Schmid, J.-P.; Vigorito, C.; et al. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur. J. Prev. Cardiol. 2021, 28, 460–495. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  88. Tanne, D.; Freimark, D.; Poreh, A.; Merzeliak, O.; Bruck, B.; Schwammenthal, Y.; Schwammenthal, E.; Motro, M.; Adler, Y. Cognitive functions in severe congestive heart failure before and after an exercise training program. Int. J. Cardiol. 2005, 103, 145–149. [Google Scholar] [CrossRef]
  89. Gunstad, J.; Macgregor, K.L.; Paul, R.H.; Poppas, A.; Jefferson, A.L.; Todaro, J.F.; Cohen, R.A. Cardiac rehabilitation improves cognitive performance in older adults with cardiovascular disease. J. Cardiopulm. Rehabil. 2005, 25, 173–176. [Google Scholar] [CrossRef] [Green Version]
  90. Stanek, K.M.; Gunstad, J.; Spitznagel, M.B.; Waechter, D.; Hughes, J.W.; Luyster, F.; Josephson, R.; Rosneck, J. Improvements in cognitive function following cardiac rehabilitation for older adults with cardiovascular disease. Int. J. Neurosci. 2011, 121, 86–93. [Google Scholar] [CrossRef]
  91. Alosco, M.L.; Spitznagel, M.B.; Cohen, R.; Sweet, L.H.; Josephson, R.; Hughes, J.; Rosneck, J.; Gunstad, J. Cardiac rehabilitation is associated with lasting improvements in cognitive function in older adults with heart failure. Acta Cardiol. 2014, 69, 407–414. [Google Scholar] [CrossRef] [PubMed]
  92. Santiago, C.; Herrmann, N.; Swardfager, W.; Saleem, M.; Oh, P.I.; Black, S.E.; Bradley, J.; Lanctôt, K.L. Subcortical hyperintensities in the cholinergic system are associated with improvements in executive function in older adults with coronary artery disease undergoing cardiac rehabilitation. Int. J. Geriatr. Psychiatry 2018, 33, 279–287. [Google Scholar] [CrossRef]
  93. Salzwedel, A.; Heidler, M.D.; Meng, K.; Schikora, M.; Wegscheider, K.; Reibis, R.; Völler, H. Impact of cognitive performance on disease-related knowledge six months after multi-component rehabilitation in patients after an acute cardiac event. Eur. J. Prev. Cardiol. 2019, 26, 46–55. [Google Scholar] [CrossRef] [PubMed]
  94. Lee, L.S.; Tsai, M.-C.; Brooks, D.; Oh, P.I. Randomised controlled trial in women with coronary artery disease investigating the effects of aerobic interval training versus moderate intensity continuous exercise in cardiac rehabilitation: CAT versus MICE study. BMJ Open Sport Exerc. Med. 2019, 5, e000589. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  95. Fujiyoshi, K.; Minami, Y.; Yamaoka-Tojo, M.; Kutsuna, T.; Obara, S.; Aoyama, A.; Ako, J. Effect of cardiac rehabilitation on cognitive function in elderly patients with cardiovascular diseases. PLoS ONE 2020, 15, e0233688. [Google Scholar] [CrossRef] [PubMed]
  96. Moriarty, T.A.; Bourbeau, K.; Mermier, C.; Kravitz, L.; Gibson, A.; Beltz, N.; Negrete, O.; Zuhl, M. Exercise-Based Cardiac Rehabilitation Improves Cognitive Function Among Patients With Cardiovascular Disease. J. Cardiopulm. Rehabil. Prev. 2020, 40, 407–413. [Google Scholar] [CrossRef]
  97. Sumida, H.; Yasunaga, Y.; Takasawa, K.; Tanaka, A.; Ida, S.; Saito, T.; Sugiyama, S.; Matsui, K.; Nakao, K.; Tsujita, K.; et al. Cognitive function in post-cardiac intensive care: Patient characteristics and impact of multidisciplinary cardiac rehabilitation. Heart Vessels. 2020, 35, 946–956. [Google Scholar] [CrossRef]
  98. Redwine, L.S.; Pung, M.A.; Wilson, K.; Bangen, K.J.; Delano-Wood, L.; Hurwitz, B. An exploratory randomized sub-study of light-to-moderate intensity exercise on cognitive function, depression symptoms and inflammation in older adults with heart failure. J. Psychosom. Res. 2020, 128, 109883. [Google Scholar] [CrossRef]
  99. Smith, K.; Moreno-Suarez, I.; Scheer, A.; Dembo, L.; Naylor, L.; Maiorana, A.; Green, D. Cerebral blood flow responses to exercise are enhanced in left ventricular assist device patients following an exercise rehabilitation program. J. Appl. Physiol. 2020, 128, 108–116. [Google Scholar] [CrossRef]
  100. Allman, J.M.; Hakeem, A.; Erwin, J.M.; Nimchinsky, E.; Hof, P. The Anterior Cingulate Cortex. Ann. N. Y. Acad. Sci. 2001, 935, 107–117. [Google Scholar] [CrossRef]
  101. Cilliers, K.; Page, B.J. Review of the Anatomy of the Distal Anterior Cerebral Artery and Its Anomalies. Turk. Neurosurg. 2016, 26, 653–661. [Google Scholar] [CrossRef] [Green Version]
  102. Saleem, M.; Herrmann, N.; Dinoff, A.; Mazereeuw, G.; Oh, P.I.; Goldstein, B.I.; Kiss, A.; Shammi, P.; Lanctôt, K.L. Association between Endothelial Function and Cognitive Performance in Patients with Coronary Artery Disease during Cardiac Rehabilitation. Psychosom. Med. 2019, 81, 184–191. [Google Scholar] [CrossRef]
  103. Weston, K.S.; Wisløff, U.; Coombes, J.S. High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: A systematic review and meta-analysis. Br. J. Sports Med. 2014, 48, 1227. [Google Scholar] [CrossRef] [PubMed]
  104. Ramos, J.S.; Dalleck, L.C.; Tjonna, A.E.; Beetham, K.S.; Coombes, J.S. The Impact of High-Intensity Interval Training Versus Moderate-Intensity Continuous Training on Vascular Function: A Systematic Review and Meta-Analysis. Sports Med. 2015, 45, 679–692. [Google Scholar] [CrossRef] [PubMed]
  105. Williams, C.J.; Gurd, B.J.; Bonafiglia, J.T.; Voisin, S.; Li, Z.; Harvey, N.; Croci, I.; Taylor, J.L.; Gajanand, T.; Ramos, J.S.; et al. A Multi-Center Comparison of VO2peak Trainability Between Interval Training and Moderate Intensity Continuous Training. Front. Physiol. 2019, 10, 19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  106. Pattyn, N.; Beulque, R.; Cornelissen, V. Aerobic Interval vs. Continuous Training in Patients with Coronary Artery Disease or Heart Failure: An Updated Systematic Review and Meta-Analysis with a Focus on Secondary Outcomes. Sports Med. 2018, 48, 1189–1205. [Google Scholar] [CrossRef] [PubMed]
  107. Qin, Y.; Kumar Bundhun, P.; Yuan, Z.L.; Chen, M.H. The effect of high-intensity interval training on exercise capacity in post-myocardial infarction patients: A systematic review and meta-analysis. Eur. J. Prev. Cardiol. 2022, 29, 475–484. [Google Scholar] [CrossRef]
  108. Taylor, J.L.; Keating, S.E.; Holland, D.J.; Green, D.J.; Coombes, J.S.; Bailey, T.G. Comparison of high intensity interval training with standard cardiac rehabilitation on vascular function. Scand. J. Med. Sci. Sports 2022, 32, 512–520. [Google Scholar] [CrossRef]
  109. Wisløff, U.; Støylen, A.; Loennechen, J.P.; Bruvold, M.; Rognmo, Ø.; Haram, P.M.; Tjønna, A.E.; Helgerud, J.; Slørdahl, S.A.; Lee, S.J.; et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: A randomized study. Circulation 2007, 115, 3086–3094. [Google Scholar] [CrossRef] [Green Version]
  110. Taylor, J.L.; Holland, D.J.; Keating, S.E.; Leveritt, M.D.; Gomersall, S.R.; Rowlands, A.V.; Bailey, T.G.; Coombes, J.S. Short-term and Long-term Feasibility, Safety, and Efficacy of High-Intensity Interval Training in Cardiac Rehabilitation: The FITR Heart Study Randomized Controlled Trial. JAMA Cardiol. 2020, 5, 1–9. [Google Scholar] [CrossRef]
  111. Rognmo, Ø.; Moholdt, T.; Bakken, H.; Hole, T.; Mølstad, P.; Myhr, N.E.; Grimsmo, J.; Wisløff, U. Cardiovascular risk of high- versus moderate-intensity aerobic exercise in coronary heart disease patients. Circulation 2012, 126, 1436–1440. [Google Scholar] [CrossRef] [Green Version]
  112. Wewege Michael, A.; Ahn, D.; Yu, J.; Liou, K.; Keech, A. High-Intensity Interval Training for Patients With Cardiovascular Disease—Is It Safe? A Systematic Review. J. Am. Heart Assoc. 2018, 7, e009305. [Google Scholar] [CrossRef]
  113. Cornelis, J.; Beckers, P.; Taeymans, J.; Vrints, C.; Vissers, D. Comparing exercise training modalities in heart failure: A systematic review and meta-analysis. Int. J. Cardiol. 2016, 221, 867–876. [Google Scholar] [CrossRef]
  114. Gayda, M.; Ribeiro, P.A.; Juneau, M.; Nigam, A. Comparison of Different Forms of Exercise Training in Patients With Cardiac Disease: Where Does High-Intensity Interval Training Fit? Can. J. Cardiol. 2016, 32, 485–494. [Google Scholar] [CrossRef] [Green Version]
  115. Taylor, J.L.; Bonikowske, A.R.; Olson, T.P. Optimizing Outcomes in Cardiac Rehabilitation: The Importance of Exercise Intensity. Front. Cardiovasc. Med. 2021, 8, 734278. [Google Scholar] [CrossRef]
  116. Taylor, J.L.; Holland, D.J.; Spathis, J.G.; Beetham, K.S.; Wisløff, U.; Keating, S.E.; Coombes, J.S. Guidelines for the delivery and monitoring of high intensity interval training in clinical populations. Prog. Cardiovasc. Dis. 2019, 62, 140–146. [Google Scholar] [CrossRef] [PubMed]
  117. Rognmo, O.; Hetland, E.; Helgerud, J.; Hoff, J.; Slordahl, S.A. High intensity aerobic interval exercise is superior to moderate intensity exercise for increasing aerobic capacity in patients with coronary artery disease. Eur. J. Cardiovasc. Prev. Rehabil. 2004, 11, 216–222. [Google Scholar] [CrossRef] [PubMed]
  118. Karlsen, T.; Aamot, I.-L.; Haykowsky, M.; Rognmo, Ø. High Intensity Interval Training for Maximizing Health Outcomes. Prog. Cardiovasc Dis. 2017, 60, 67–77. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  119. Taylor, J.L.; Holland, D.J.; Keating, S.E.; Bonikowske, A.R.; Coombes, J.S. Adherence to High-Intensity Interval Training in Cardiac Rehabilitation: A Review and Recommendations. J. Cardiopulm. Rehabil. Prev. 2021, 41, 61–77. [Google Scholar] [CrossRef]
  120. Calverley, T.A.; Ogoh, S.; Marley, C.J.; Steggall, M.; Marchi, N.; Brassard, P.; Lucas, S.J.E.; Cotter, J.D.; Roig, M.; Ainslie, P.N.; et al. HIITing the brain with exercise; mechanisms, consequences and practical recommendations. J. Physiol. 2020, 598, 2513–2530. [Google Scholar] [CrossRef]
  121. Ogoh, S.; Washio, T.; Suzuki, K.; Iemitsu, M.; Hashimoto, T.; Iwamoto, E.; Bailey, D.M. Greater increase in internal carotid artery shear rate during aerobic interval compared to continuous exercise in healthy adult men. Physiol. Rep. 2021, 9, e14705. [Google Scholar] [CrossRef]
  122. Klein, T.; Bailey, T.G.; Abeln, V.; Schneider, S.; Askew, C.D. Cerebral Blood Flow during Interval and Continuous Exercise in Young and Old Men. Med. Sci. Sports Exerc. 2019, 51, 1523–1531. [Google Scholar] [CrossRef]
  123. Ogoh, S.; Ainslie, P.N. Cerebral blood flow during exercise: Mechanisms of regulation. J. Appl. Physiol. 2009, 107, 1370–1380. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  124. Lucas, S.; Cotter, J.; Brassard, P.; Bailey, D. High-intensity interval exercise and cerebrovascular health: Curiosity, cause, and consequence. J. Cereb. Blood Flow Metab. 2015, 35, 902–911. [Google Scholar] [CrossRef] [PubMed]
  125. Faull, O.K.; Cotter, J.D.; Lucas, S.J. Cerebrovascular responses during rowing: Do circadian rhythms explain morning and afternoon performance differences? Scand. J. Med. Sci. Sports 2015, 25, 467–475. [Google Scholar] [CrossRef] [PubMed]
  126. Furlong, R.J.; Weaver, S.R.; Sutherland, R.; Burley, C.V.; Imi, G.M.; Lucas, R.A.I.; Lucas, S.J.E. Exercise-induced elevations in cerebral blood velocity are greater in running compared to cycling at higher intensities. Physiol. Rep. 2020, 8, e14539. [Google Scholar] [CrossRef] [PubMed]
  127. Whitaker, A.A.; Alwatban, M.; Freemyer, A.; Perales-Puchalt, J.; Billinger, S.A. Effects of high intensity interval exercise on cerebrovascular function: A systematic review. PLoS ONE 2020, 15, e0241248. [Google Scholar] [CrossRef]
  128. Coetsee, C.; Terblanche, E. Cerebral oxygenation during cortical activation: The differential influence of three exercise training modalities. A randomized controlled trial. Eur. J. Appl. Physiol. 2017, 117, 1617–1627. [Google Scholar] [CrossRef]
  129. Drapeau, A.; Labrecque, L.; Imhoff, S.; Paquette, M.; Le Blanc, O.; Malenfant, S.; Brassard, P. Six weeks of high-intensity interval training to exhaustion attenuates dynamic cerebral autoregulation without influencing resting cerebral blood velocity in young fit men. Physiol. Rep. 2019, 7, e14185. [Google Scholar] [CrossRef] [Green Version]
  130. Kovacevic, A.; Fenesi, B.; Paolucci, E.; Heisz, J.J. The effects of aerobic exercise intensity on memory in older adults. Appl. Physiol. Nutr. Metab. 2019, 45, 591–600. [Google Scholar] [CrossRef]
  131. Mekari, S.; Earle, M.; Martins, R.; Drisdelle, S.; Killen, M.; Bouffard-Levasseur, V.; Dupuy, O. Effect of High Intensity Interval Training Compared to Continuous Training on Cognitive Performance in Young Healthy Adults: A Pilot Study. Brain Sci. 2020, 10, 81. [Google Scholar] [CrossRef]
Ijerph 19 16926 g001 550
Figure 1. Potential mechanisms for how high intensity exercise can improve brain health. Abbreviations: BDNF: brain-derived neurotrophic factor; CVD: Cardiovascular disease; HIIT: high intensity interval training; IGF-1: insulin-like growth factor 1; ↑: increase, ↓: decrease.
Figure 1. Potential mechanisms for how high intensity exercise can improve brain health. Abbreviations: BDNF: brain-derived neurotrophic factor; CVD: Cardiovascular disease; HIIT: high intensity interval training; IGF-1: insulin-like growth factor 1; ↑: increase, ↓: decrease.
Ijerph 19 16926 g001
Table
Table 1. Chronic Exercise Training Studies in Patients with CVD Assessing Change in Brain-related Outcomes.
Table 1. Chronic Exercise Training Studies in Patients with CVD Assessing Change in Brain-related Outcomes.
Study, Year, Design, and Sample Size Patient CharacteristicsExercise InterventionChange in Exercise CapacitySummary of Brain-Related Outcome Results
Tanne et al. [88] (2005)
Controlled Trial; Ex = 20, Control = 5		HF—NYHA III
63 ± 13 years; 20% F
BMI: 26.7
EF: 26 ± 5%
6 MWT: 308 ± 87 m		18-week CR; 2 d/w Aerobic; 50 min
60–70% HRmax		↑ 6 MWT distance
(MD = 115 m)
↑ Modified Bruce Test
(MD = 4.2 min)		Cognition: (+) Improved Attention-Psychomotor (TMT-A) and Executive functions (TMT-B, Stroop-A) for Ex group only. (−) NSC in Global function (MMSE), Visuospatial memory (Rey-Osterrieth Complex Figure), Language (Verbal fluency), and Stroop B + C or Continuous performance test.
MCAv (TCD): (−) NSC in MCAv & CVR breath-hold index
Other Hemodynamics: (+) Improved CV hemodynamics (↑ cardiac index & ↓ systemic vascular resistance).
Gunstad et al. [89] (2005)
Case-Series;
Ex = 18, no Control		CAD/CABG/HF
68 ± 8 years; 28% F
METs: 5.2 ± 2.0		12-week CR; 3 d/w
Aerobic; 10–45 min
Intensity NR		↑ Peak METs on clinical stress test (MD = 2.2)Cognition: (+) Improved Attention-Psychomotor function (TMT-A & DSC)
(−) NSC in GP & Language (Animal fluency).
Stanek et al. [90] (2011)
Case-Series;
Ex = 51, no Control		CAD/CABG/HF
68 ± 9 years; 35% F
BMI: 31.3
METs: 7.2 ± 2.7		12-week CR; 3 d/w
Aerobic; 60 min
Intensity NR		↑ Peak METs
(MD = 2.8)		Cognition: (+) Improved Attention-Psychomotor function (LNS, GP) & Verbal Memory (HVLT) > practice effects. (+) Improved Global function (Modified MMSE) and Visuospatial Memory (BVMT) = practice effects. (−) NSC Executive function (TMT, FAB) or Language (Animal fluency, Boston naming).
MCAv and ACAv (TCD): (+) ↑ACAv. (−) NSC in MCAv or pulsatility index.
Anazodo et al. [15] (2013); Case-Series;
Ex = 24, no Control
Anazodo et al. [14] (2016); Ex = 17		CAD
59 ± 6 years; 25% F
BMI: 29.8 ± 4.7
EF: 64 ± 8%
PeakVO2: 26 ± 2		6-month CR; 3 d/w Aerobic + RT
20–30 min
RPE 11–14
40–70%HRR 		NSC PeakVO2
(MD = 5% increase, 1.3 mL/kg/min)		Cognition: (−) NSC MoCA score.
Brain structure: (+) ↑ Gray matter volume bilaterally in frontal lobe, middle temporal gyrus, supplementary motor area.
CBF (ASL): (+) ↑ Regional gray matter CBF in bilateral Anterior Cingulate.
(−) NSC in Global Gray Matter CBF.
Alosco et al. [91] (2014)
Case-Series;
Ex = 52, no Control		HF—NYHA II/III
67 ± 8 years; 25% F
EF: 39 ± 12%
2-min step test: 72 ± 20		12-week CR; 3 d/w Aerobic; 40 min
Intensity NR		↑ 2-min step test over 12-wk (MD = 4)
NSC 2-min step test over 12-months (MD = 5)		Cognition: (+) Improved Attention-Psychomotor function (DSC) at 12-wks & 12-months. (+) Improved Verbal Memory (CVLT-II) at 12-months but NSC at 12-wks.
(−) NSC in Global function (MMSE), Executive function (TMT-B), Language (Animal Fluency, Boston Naming), or TMT-A.
Santiago et al. [92]
(2018) Case-Series;
Ex = 50, no Control		ACS
67 ± 7 years; 16% F
BMI: 28.6 ± 4.2
PeakVO2: 19 ± 5		48-week CR; 1 d/w
+ 4 d/w at home
Aerobic + RT
Walk/jog; Intensity NR		↑ PeakVO2
(MD = 28%, 5.3 mL/kg/min)		Cognition: (+) Improved Attention-Psychomotor function (TMT-A, DSC) & Verbal memory (CVLT-II).
(−) NSC in Executive function (TMT-B), Visuospatial memory (BVMT-R), & Language (Animal fluency, FAS Verbal fluency).
Salzwedel et al. [93] (2019) Cohort Study;
Ex = 401, no control		ACS/CABG
55 ± 6 years; 20% F
BMI 28.7 ± 5.1		3-week CR
Exercise details NR		↑ 6 MWT distance
(MD = 83 m)		Cognition: (+) Improved MoCA score.
Lee et al. [94] (2019)
RCT; Ex1 = 7, Ex2 = 7, no control		CAD/PCI/CABG
68 ± 9 years; 100% F
BMI 28 ± 6
EF: >35%
PeakVO2: 19 ± 4		24-week CR; 5 d/w
Aerobic walk/jog
Ex1: 30–40 min
60–80% PeakVO2
Ex2: 4 × 4 min 90–95% PeakHR RPE > 17 3 d/w + MICE 2 d/w		↑ PeakVO2 for Ex2
(MD = 7%; 1.3 mL/kg)
NSC PeakVO2 for Ex1
(MD = 2% 0.4 mL/kg).
NS difference between groups.		Cognition: (−) NSC in Attention-Psychomotor function (DSC), Executive function (TMT-B, Digit span test), and Verbal Memory (CVLT-II) for moderate intensity (Ex1) or aerobic interval training (Ex2) groups.
Fujiyoshi et al. [95] (2020) Controlled Trial; Ex1 = 27, Ex2 = 39CVD
77 ± 5 years; 44% F
BMI: 24 ± 3 y
6 MWT: 465 ± 98 m		6-month CR
Aerobic + RT
BORG 10–13
Ex1: 1/month
Ex2: <1/month		↑ 6 MWT distance for Ex1
(MD = 40 m)
NSC 6 MWT distance for Ex2
(MD = −14 m)		Cognition: (+) Improvement in Global (MMSE) and Executive functions (FAB) was significantly greater monthly CR (Ex1) than <monthly CR (Ex2), specifically improved were temporal orientation, attention, calculation, No/No-Go task).
Vascular function: (+) Improvement in vascular function (as reactive hyperemia peripheral arterial tonometry) was significantly greater with monthly CR (Ex1) than the <monthly CR (Ex2).
Moriarty et al. [96] (2020) Case-Series;
Ex = 20, no Control		CVD
65 ± 12 years; 25% F
BMI: 29 ± 6 y
METs: 5.5 ± 2.5		6-week CR
3 d/w, 30–60 min
50–80%HRR
RPE 3–5/10		↑ METs from submaximal treadmill test (MD = 1.4) Cognition: (+) Improved Global function (NIH Toolbox Fluid Composite score), and specifically Attention, Processing Speed, Executive Function, Visuospatial Working Memory. (−) NSC in Episodic (Verbal) Memory.
Cerebral oxygenation (NIRS): (+) Improved oxygenation of right and left pre-frontal cortex during cognitive testing
Sumida et al. [97] (2020); Cohort Study
Ex = 111, no Control		ACS/CABG/HF
Age: 77 years
BMI: 22		2–6 week inpatient CR; 2–3 d/w;
Intensity NR		↑ FIM-Physical scoreCognition: (+) Improved Functional Independence Measure (FIM-Cognitive).
Redwine et al. [98] (2020); RCT; Ex1 = 24, Ex2 = 22, Control = 23Symptomatic HF
65 ± 10 years; 11% F
LVEF: 46 ± 14%		16-week; 2 d/w; 60 min; RPE 11–13
Ex1: Tai Chi; Ex2:RT		None reportedCognition: (+) Improved MoCA score for Ex groups (Tai Chi & RT) compared with Control.
Smith et al. [99] (2020)
Case-Series;
Ex = 12, no Control		LVAD
54 ± 12 years; 42% F
PeakVO2: 12 ± 3		12-week CR
3 d/w, 60 min
Aerobic + RT
59–90% VO2R; RPE 11–15; 50–60%1 RM		↑ PeakVO2
(MD = 25%; 2.9 mL/kg)		Cognition: Not assessed.
MCAv and PCAv (TCD): (+) Improved PCAv regulation during maximal exercise following the training period. Improved ICA flow regulation during submaximal exercise following training period. NSC in MCAv regulation. (−) Decrease in resting PCAv. NSC in resting MCAv.
Abbreviations: ACAv: Anterior cerebral artery velocity; ACS: Acute Coronary Syndrome; ASL: Arterial-spin Labelling; BVMT: Brief Visual Memory Test; CABG: Coronary artery bypass graft surgery; CAD: Coronary Artery Disease; CR: Cardiac rehabilitation; CVD: Cardiovascular disease; CVLT: California Verbal Learning Test; DSC: Digit Symbol Coding Test; Ex: Exercise group; FAB: Frontal Assessment Board; GP: Grooved Pegboard; HF: Heart Failure; HVLT: Hopkins Verbal Learning Test; HR: Heart rate; HRR: Heart rate reserve; ICA: Internal carotid artery; LNS: Letter-number Sequencing; LVEF: Left ventricular ejection fraction; MCAv: Middle cerebral artery velocity; MD: Mean Difference; METs: Metabolic equivalents; MoCA: Montreal Cognitive Assessment; NIRS: Near-infrared Spectroscopy; NR: Not reported; NSC: non-significant change; PeakVO2: Peak Oxygen Uptake; PCAv: Posterior cerebral artery velocity; RCT: Randomized Controlled Trial; RM: Repetition maximum; RT: Resistance training; SVR: systemic vascular resistance; TCD: Transcranial doppler ultrasound; TMT: Trail-making Test; LVAD: left ventricular assist device; VO2R: oxygen uptake reserve; ↑: increase; ↓: decrease.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Taylor, J.L.; Barnes, J.N.; Johnson, B.D. The Utility of High Intensity Interval Training to Improve Cognitive Aging in Heart Disease Patients. Int. J. Environ. Res. Public Health 2022, 19, 16926. https://doi.org/10.3390/ijerph192416926

AMA Style

Taylor JL, Barnes JN, Johnson BD. The Utility of High Intensity Interval Training to Improve Cognitive Aging in Heart Disease Patients. International Journal of Environmental Research and Public Health. 2022; 19(24):16926. https://doi.org/10.3390/ijerph192416926

Chicago/Turabian Style

Taylor, Jenna L., Jill N. Barnes, and Bruce D. Johnson. 2022. "The Utility of High Intensity Interval Training to Improve Cognitive Aging in Heart Disease Patients" International Journal of Environmental Research and Public Health 19, no. 24: 16926. https://doi.org/10.3390/ijerph192416926

APA Style

Taylor, J. L., Barnes, J. N., & Johnson, B. D. (2022). The Utility of High Intensity Interval Training to Improve Cognitive Aging in Heart Disease Patients. International Journal of Environmental Research and Public Health, 19(24), 16926. https://doi.org/10.3390/ijerph192416926

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop